The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of KD033, an anti-human-PD-L1-IL-15 bispecific protein, in human-PD-L1 positive and negative murine tumor models.
 
Stella Martomo
Employment - Kadmon
Stock and Other Ownership Interests - Kadmon
Honoraria - Kadmon
Research Funding - Kadmon
Patents, Royalties, Other Intellectual Property - Patent
Travel, Accommodations, Expenses - Kadmon
 
Dan Lu
Employment - Alvogen (I); Kadmon
Stock and Other Ownership Interests - Kadmon; Lilly; Teva (I)
Patents, Royalties, Other Intellectual Property - Flt-3 antibody (Inst); PD1 antibody and I15 fusions (Inst); PDL1 antibody and fusions (Inst); VEGFR2 antibody (Inst)
 
Zhanna Polonskaya
Employment - Kadmon
Stock and Other Ownership Interests - Kadmon
Honoraria - Kadmon
Research Funding - Kadmon
Patents, Royalties, Other Intellectual Property - Kadmon
 
Xenia Luna
Employment - Kadmon
Stock and Other Ownership Interests - Kadmon
Honoraria - Kadmon
 
Zhikai Zhang
Employment - Kadmon
Stock and Other Ownership Interests - Kadmon
Honoraria - Kadmon
 
Galit Regev
No Relationships to Disclose
 
Olivier Schueller
Employment - Kadmon
 
Jeegar Patel
Employment - Kadmon
Stock and Other Ownership Interests - Kadmon
Travel, Accommodations, Expenses - Kadmon